Mary Dorholt, PharmD

The number of drugs approved for orphan conditions has increased in recent years, and specialty pharmacies play an important role in the management of therapies for patients with rare diseases.

Individualized care programs can help patients with pulmonary arterial hypertension manage complex treatment regimens and overcome the challenges presented by this condition.

New drugs to treat hepatitis C herald a new era of higher cure rates, but with these new treatment options comes an increased need for patient support and adherence counseling.

With cancer ranking third among disease states in specialty spending, there is a growing emphasis on programs that focus on cost management and patient adherence to complex medication regimens.